The analysts of Healthcare Intelligence Markets have thoroughly examined the Global Pain Management Market and have anticipated that the market will grow at a CAGR of +7% during the forecast period.
Pain is a stressful sensory and emotional feeling, which befalls due to tissue impairment or illness. In addition to this, various diseases, such as, osteoarthritis, multiple sclerosis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer can cause tremendous pain. The duration of this pain differs from short term known as acute pain to long term stated as chronic pain. Acute pain is an unexpected onset of pain, whereas chronic pain occurs due to aging conditions of bone & joints, nerve damage, or injury. The controlling of pain involves decrease or treatment of pain using a particular set of drugs. Various drugs are available which provide pain relief through a variety of physiological mechanism, such as by aiming at the nociceptors.
For Sample Copy of This report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=29030
The increase in geriatric population, changing lifestyles, the high prevalence of chronic pain and the upsurge in the awareness of the same are the major key factors which is driving the growth of the pain management market.
The Pain Management Market provides its segmentations by regions such as North America, Europe, Asia Pacific and LAMEA. Along with this, it also provides an in-depth analysis of the prominent factors that influence the market which includes drivers, opportunities, trends and industry-specific challenges.
Globally North American region holds the largest share of the market is followed by Europe, Asia Pacific, 2018-2023.
Avail Discount on This report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29030
Some of the players operating in the pain management market are Becton, Dickinson and Company, Boston Scientific Corporation, Braun Melsungen AG, Halyard Health, Inc., Hospira, Inc., Medtronic PLC., Neurotech Na, Inc., Nevro Corp., Smiths Medical, ST. Jude Medical, Inc., among the others.
Boston Scientific Corporation has come up with its new invention for Radiofrequency Ablation for Pain Management named G4™ RF. It is designed to deliver consistent, reliable results, and also offers a wide range of treatment options in an easy-to-use interface.
The development of the novel pain management devices among the others is the major key driving factor for this market. On the other hand, factors like shortage of pain specialists, low number of pain clinics in several countries and high procedural and purchase cost can limit the growth of the market. But, the extensive R&D activities and clinical validation of the safety and efficacy these devices are the major factors that will develop the market in the near future.
• By Drug Class
o Antimigraine Agents
o Nonnarcotic Analgesics
• By Indication
o Arthritic Pain
o Neuropathic Pain
o Cancer Pain
o Chronic Back Pain
o Postoperative Pain
• By Region
o North America
o Asia Pacific